DGX Insider Transactions — Page 2
571 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 101–200; provenance stays internal.
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| RING TIMOTHY M | Director | 2022-10-03 | Sale | 2,000.0 | $123.39 |
| RING TIMOTHY M | Director | 2022-09-01 | Sale | 2,000.0 | $125.02 |
| RING TIMOTHY M | Director | 2022-08-01 | Sale | 2,000.0 | $136.04 |
| RING TIMOTHY M | Director | 2022-07-01 | Sale | 2,000.0 | $133.47 |
| RUSCKOWSKI STEPHEN H | Chairman, CEO and President | 2022-05-25 | Sale | 900.0 | $142.13 |
| RUSCKOWSKI STEPHEN H | Chairman, CEO and President | 2022-05-25 | Sale | 4,131.0 | $141.35 |
| RUSCKOWSKI STEPHEN H | Chairman, CEO and President | 2022-05-25 | Sale | 9,823.0 | $140.58 |
| RUSCKOWSKI STEPHEN H | Chairman, CEO and President | 2022-05-25 | Sale | 651.0 | $142.15 |
| RUSCKOWSKI STEPHEN H | Chairman, CEO and President | 2022-05-25 | Sale | 2,565.0 | $141.36 |
| RUSCKOWSKI STEPHEN H | Chairman, CEO and President | 2022-05-25 | Sale | 6,821.0 | $140.6 |
| RUSCKOWSKI STEPHEN H | Chairman, CEO and President | 2022-05-24 | Sale | 156,282.0 | $140.12 |
| RUSCKOWSKI STEPHEN H | Chairman, CEO and President | 2022-05-24 | Sale | 126,126.0 | $140.12 |
| RUSCKOWSKI STEPHEN H | Chairman, CEO and President | 2022-05-23 | Sale | 300.0 | $142.24 |
| RUSCKOWSKI STEPHEN H | Chairman, CEO and President | 2022-05-23 | Sale | 1,000.0 | $141.51 |
| RUSCKOWSKI STEPHEN H | Chairman, CEO and President | 2022-05-23 | Sale | 41,268.0 | $140.12 |
| RUSCKOWSKI STEPHEN H | Chairman, CEO and President | 2022-05-23 | Sale | 200.0 | $142.26 |
| RUSCKOWSKI STEPHEN H | Chairman, CEO and President | 2022-05-23 | Sale | 800.0 | $141.54 |
| RUSCKOWSKI STEPHEN H | Chairman, CEO and President | 2022-05-23 | Sale | 33,898.0 | $140.12 |
| PREVOZNIK MICHAEL E | SVP & General Counsel | 2022-05-17 | Sale | 50,604.0 | $139.97 |
| PREVOZNIK MICHAEL E | SVP & General Counsel | 2022-03-08 | Sale | 6,228.0 | $135.21 |
| Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | 2022-03-08 | Sale | 7,032.0 | $135.21 |
| PREVOZNIK MICHAEL E | SVP & General Counsel | 2022-02-28 | Sale | 661.0 | $130.0 |
| Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | 2022-02-24 | Sale | 2,750.0 | $126.26 |
| PREVOZNIK MICHAEL E | SVP & General Counsel | 2022-02-24 | Sale | 1,669.0 | $126.26 |
| Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | 2021-11-29 | Sale | 14,575.0 | $157.53 |
| Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | 2021-11-29 | Sale | 15,908.0 | $156.86 |
| Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | 2021-11-29 | Sale | 3,532.0 | $155.77 |
| Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | 2021-11-29 | Sale | 3,250.0 | $154.79 |
| Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | 2021-11-29 | Sale | 300.0 | $153.38 |
| RUSCKOWSKI STEPHEN H | Chairman, CEO and President | 2021-07-29 | Sale | 4,193.0 | $141.22 |
| RUSCKOWSKI STEPHEN H | Chairman, CEO and President | 2021-07-29 | Sale | 5,300.0 | $140.59 |
| RUSCKOWSKI STEPHEN H | Chairman, CEO and President | 2021-07-28 | Sale | 139,751.0 | $140.14 |
| RUSCKOWSKI STEPHEN H | Chairman, CEO and President | 2021-07-27 | Sale | 32,788.0 | $140.01 |
| WILENSKY GAIL R | Director | 2021-07-27 | Sale | 6,111.0 | $139.27 |
| WILENSKY GAIL R | Director | 2021-07-27 | Sale | 6,111.0 | $139.32 |
| RUSCKOWSKI STEPHEN H | Chairman, CEO and President | 2021-07-26 | Sale | 5,813.0 | $140.03 |
| Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | 2021-05-07 | Sale | 8,536.0 | $139.96 |
| PREVOZNIK MICHAEL E | SVP & General Counsel | 2021-05-05 | Sale | 44,939.0 | $137.0 |
| PREVOZNIK MICHAEL E | SVP & General Counsel | 2021-03-10 | Sale | 5,574.0 | $120.47 |
| PREVOZNIK MICHAEL E | SVP & General Counsel | 2021-02-25 | Sale | 801.0 | $115.49 |
| PREVOZNIK MICHAEL E | SVP & General Counsel | 2021-02-24 | Sale | 750.0 | $116.95 |
| PREVOZNIK MICHAEL E | SVP & General Counsel | 2021-02-24 | Sale | 438.0 | $116.95 |
| GUINAN MARK | Executive Vice President & CFO | 2020-12-24 | Sale | 22,563.0 | $121.18 |
| GUINAN MARK | Executive Vice President & CFO | 2020-12-24 | Sale | 59,193.0 | $120.06 |
| WILENSKY GAIL R | Director | 2020-11-24 | Sale | 6,111.0 | $126.02 |
| STANZIONE DANIEL | Director | 2020-11-23 | Sale | 2,300.0 | $127.45 |
| STANZIONE DANIEL | Director | 2020-11-23 | Sale | 3,302.0 | $126.46 |
| STANZIONE DANIEL | Director | 2020-11-23 | Sale | 5,621.0 | $125.73 |
| DEPPE MICHAEL J | VP, Corp. Controller & CAO | 2020-10-21 | Sale | 4,750.0 | $125.0 |
| DEPPE MICHAEL J | VP, Corp. Controller & CAO | 2020-10-21 | Sale | 5,700.0 | $125.0 |
| RUSCKOWSKI STEPHEN H | Chairman, CEO and President | 2020-10-16 | Sale | 291,997.0 | $120.0 |
| PREVOZNIK MICHAEL E | SVP & General Counsel | 2020-10-14 | Sale | 35,591.0 | $119.0 |
| Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | 2020-09-02 | Sale | 3,776.0 | $111.13 |
| Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | 2020-09-02 | Sale | 54,616.0 | $110.57 |
| GUINAN MARK | Executive Vice President & CFO | 2020-06-08 | Sale | 8,524.0 | $118.6 |
| GUINAN MARK | Executive Vice President & CFO | 2020-06-08 | Sale | 18,246.0 | $117.65 |
| GUINAN MARK | Executive Vice President & CFO | 2020-06-08 | Sale | 45,826.0 | $116.81 |
| RING TIMOTHY M | Director | 2020-06-08 | Sale | 11,730.0 | $116.6 |
| RUSCKOWSKI STEPHEN H | Chairman, CEO and President | 2020-04-27 | Sale | 11,717.0 | $112.01 |
| EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | 2020-04-27 | Sale | 2,500.0 | $110.0 |
| EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | 2020-04-27 | Sale | 2,500.0 | $112.03 |
| Davis J. E. | EVP, General Diagnostics | 2020-03-16 | Sale | 500.0 | $90.15 |
| Davis J. E. | EVP, General Diagnostics | 2020-03-16 | Sale | 421.0 | $88.53 |
| Davis J. E. | EVP, General Diagnostics | 2020-03-16 | Sale | 1,307.0 | $87.81 |
| Davis J. E. | EVP, General Diagnostics | 2020-03-16 | Sale | 1,085.0 | $86.65 |
| Davis J. E. | EVP, General Diagnostics | 2020-03-16 | Sale | 200.0 | $85.59 |
| PREVOZNIK MICHAEL E | SVP & General Counsel | 2020-03-11 | Sale | 2,175.0 | $104.25 |
| Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | 2020-03-11 | Sale | 2,501.0 | $104.25 |
| RUSCKOWSKI STEPHEN H | Chairman, CEO and President | 2020-03-10 | Sale | 100.0 | $112.19 |
| RUSCKOWSKI STEPHEN H | Chairman, CEO and President | 2020-03-06 | Sale | 2,000.0 | $116.27 |
| RUSCKOWSKI STEPHEN H | Chairman, CEO and President | 2020-03-06 | Sale | 3,937.0 | $115.45 |
| RUSCKOWSKI STEPHEN H | Chairman, CEO and President | 2020-03-06 | Sale | 16,426.0 | $114.24 |
| RUSCKOWSKI STEPHEN H | Chairman, CEO and President | 2020-03-06 | Sale | 36,790.0 | $113.65 |
| RUSCKOWSKI STEPHEN H | Chairman, CEO and President | 2020-03-06 | Sale | 171,025.0 | $112.21 |
| PREVOZNIK MICHAEL E | SVP & General Counsel | 2020-02-27 | Sale | 690.0 | $109.02 |
| Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | 2020-02-27 | Sale | 789.0 | $109.02 |
| Davis J. E. | EVP, General Diagnostics | 2020-02-27 | Sale | 1,100.0 | $109.02 |
| PREVOZNIK MICHAEL E | SVP & General Counsel | 2020-02-26 | Sale | 321.0 | $111.09 |
| Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | 2020-02-26 | Sale | 368.0 | $111.09 |
| Davis J. E. | EVP, General Diagnostics | 2020-02-26 | Sale | 510.0 | $111.09 |
| Davis J. E. | EVP, General Diagnostics | 2020-02-25 | Sale | 598.0 | $112.73 |
| Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | 2020-02-25 | Sale | 405.0 | $112.73 |
| Davis J. E. | EVP, General Diagnostics | 2020-01-02 | Sale | 8,853.0 | $106.51 |
| Davis J. E. | EVP, General Diagnostics | 2020-01-02 | Sale | 69,003.0 | $105.45 |
| Davis J. E. | EVP, General Diagnostics | 2020-01-02 | Sale | 7,423.0 | $106.51 |
| Davis J. E. | EVP, General Diagnostics | 2020-01-02 | Sale | 58,258.0 | $105.46 |
| PREVOZNIK MICHAEL E | SVP & General Counsel | 2019-11-27 | Sale | 500.0 | $107.83 |
| PREVOZNIK MICHAEL E | SVP & General Counsel | 2019-11-27 | Sale | 32,193.0 | $107.53 |
| PREVOZNIK MICHAEL E | SVP & General Counsel | 2019-11-27 | Sale | 11,863.0 | $107.15 |
| WILENSKY GAIL R | Director | 2019-11-26 | Sale | 8,000.0 | $107.17 |
| DEPPE MICHAEL J | VP, Corp. Controller & CAO | 2019-09-17 | Sale | 5,000.0 | $106.0 |
| RUSCKOWSKI STEPHEN H | Chairman, President and CEO | 2019-06-13 | Sale | 244,565.0 | $100.0 |
| GUINAN MARK | Executive Vice President & CFO | 2019-06-13 | Sale | 73,005.0 | $100.0 |
| Davis J. E. | EVP, General Diagnostics | 2019-04-24 | Sale | 47,574.0 | $95.0 |
| Davis J. E. | EVP, General Diagnostics | 2019-04-08 | Sale | 2,100.0 | $90.7 |
| Davis J. E. | EVP, General Diagnostics | 2019-04-08 | Sale | 5,900.0 | $90.15 |
| Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | 2019-04-04 | Sale | 5,890.0 | $90.59 |
| Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | 2019-04-04 | Sale | 60,492.0 | $90.59 |
| PREVOZNIK MICHAEL E | SVP & General Counsel | 2019-03-04 | Sale | 3,373.0 | $86.81 |
| Cunningham Everett | SVP, Commercial | 2019-03-04 | Sale | 3,892.0 | $86.81 |